The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Lipoatrophy Revisited
Abstract
The lipoatrophy syndromes are a heterogeneous group of syndromes characterized by a paucity of adipose tissue. Severe lipoatrophy is associated with insulin-resistant diabetes mellitus (DM). The loss of adipose tissue can have a genetic, immune, or infectious/drug-associated etiology. Causative mutations have been identified in patients for one form of partial lipoatrophy--Dunnigan-type familial partial lipodystrophy. Experiments using lipoatrophic mice demonstrate that the diabetes results from the lack of fat and that leptin deficiency is a contributing factor. Thiazolidinedione therapy improves metabolic control in lipoatrophic patients; the efficacy of leptin treatment is currently being investigated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lipodystrophy is a rare disorder that is characterized by selective loss of subcutaneous and visceral fat. This disease is associated with hypertriglyceridemia, hepatic steatosis, and severe insulin resistance that often results in diabetes (1-3).”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [2]
In the citing paper
“generalized lipodystrophy in rodents and patients constituted a severe hypoleptinemic state (2,3).”
From Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy (2005) · cites this paper as [3]
Citations
Cites
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Carr, A., Samaras, K., Burton, S., Law, M. G., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,364
Environmental Contributions to the Obesity Epidemic
Hill, J. O., & Peters, J. C. (1998) · Science · doi:10.1126/science.280.5368.1371 · Cited by 2,258
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
Bonne, G., di Barletta, M. R., Varnous, S., Bécane, H. M., Hammouda, E.-H., Merlini, L., Muntoni, F., Greenberg, C. R., Gary, F., Urtizberea, J. A., et al. (1999) · Nature Genetics · doi:10.1038/6799 · Cited by 1,384
Fatkin, D., MacRae, C. A., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M. P., Atherton, J. J., Vidaillet, H. J., Jr., Spudich, S., Girolami, U. D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,366
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790
Research works printed but not linked: 1
- Foster, D.W. (1998) The lipodystrophies and other rare disorders of adipose tissue. In Harrison's Principles of Internal Medicine (Fauci, A.S. et al., eds), pp. 2209–2214, McGraw–Hill
Cited by
Sorted by citations
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
Self-citationSeppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 955
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923
Diabetes, Obesity, and the Brain
Schwartz, M. W., & Porte, D. (2005) · Science · doi:10.1126/science.1104344 · Cited by 841
Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800
Self-citationKotronen, A., & Yki‐Järvinen, H. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 793
Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300043200 · Cited by 707
Self-citationGarofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726
Havel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 536
Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A., & Smith, U. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2017 · Cited by 462
Adipocyte Differentiation: From Fibroblast to Endocrine Cell
Gregoire, F. M. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020122601106 · Cited by 438
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R., Umpleby, A. M., Thomas, E. L., Bell, J. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.4.910 · Cited by 423
Insulin resistance and impaired adipogenesis
Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A., & Smith, U. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.01.006 · Cited by 407
Leptin: Structure, Function and Biology
Zhang, F. P. Y., Chen, Y., Heiman, M. L., & DiMarchi, R. D. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71012-8 · Cited by 353
Westerbacka, J., Corn�r, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., H�kkinen, A.-M., Fredriksson, J., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1460-1 · Cited by 338
Variation in Type 2 Diabetes-Related Traits in Mouse Strains Susceptible to Diet-Induced Obesity
Rossmeisl, M., Rim, J. S., Koza, R. A., & Kozak, L. P. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1958 · Cited by 288
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Fat in the liver and insulin resistance
Yki‐Järvinen, H. (2005) · Annals of Medicine · doi:10.1080/07853890510037383 · Cited by 269
Visceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 287
Analysis of paradoxical observations on the association between leptin and insulin resistance
Ceddia, R. B., Koistinen, H. A., Zierath, J. R., & Sweeney, G. (2002) · The FASEB Journal · doi:10.1096/fj.02-0158rev · Cited by 258
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
Maldergem, L. V., Magré, J., Khallouf, T. E., Gedde‐Dahl, T., Délepine, M., Trygstad, O., Seemanová, E., Stephenson, T. J., Albott, C. S., Bonńici, F., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.10.722 · Cited by 250
Leptin Function and Regulation
Zhang, Y., & Chua, S. C. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160041 · Cited by 284
Crux, N. B., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00832 · Cited by 248
Long-Term Efficacy of Leptin Replacement in Patients With Generalized Lipodystrophy
Javor, E. D., Cochran, E. K., Musso, C., Young, J. R., DePaoli, A. M., & Gorden, P. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1994 · Cited by 226
Addy, C., Gavrila, A., Tsiodras, S., Brodovicz, K. G., Karchmer, A. W., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020795 · Cited by 218
Vigouroux, C., Maachi, M., Nguyên, T.-H., Coussieu, C., Gharakhanian, S., Funahashi, T., Matsuzawa, Y., Shimomura, I., Rozenbaum, W., Capeau, J., et al. (2003) · AIDS · doi:10.1097/00002030-200307040-00011 · Cited by 210
Phan, J., Péterfy, M., & Reue, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403506200 · Cited by 203
Raubenheimer, P. J., Nyirenda, M., & Walker, B. R. (2006) · Diabetes · doi:10.2337/db06-0097 · Cited by 199
Chou, C. J., Haluzı́k, M., Gregory, C., Dietz, K. R., Vinson, C., Gavrilova, O., & Reitman, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202449200 · Cited by 197
Self-citationYang, X., & Smith, U. (2007) · Diabetologia · doi:10.1007/s00125-007-0640-1 · Cited by 197
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
Lafontan, M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095843 · Cited by 191
Haluzı́k, M., Colombo, C., Gavrilova, O., Chua, S. C., Wolf, N., Chen, M., STANNARD, B. S., Dietz, K. R., Roith, D. L., & Reitman, M. L. (2004) · Endocrinology · doi:10.1210/en.2004-0219 · Cited by 180
Self-citationThe Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
Gurnell, M., Savage, D. B., Chatterjee, K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 178
Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation
Alessi, M., Bastelica, D., Mavri, A., Morange, P., Berthet, B., Grino, M., & Juhan-Vague, I. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000077401.36885.bb · Cited by 178
Poirier, H., Shapiro, J. S., Kim, R. J., & Lazar, M. A. (2006) · Diabetes · doi:10.2337/db06-0036 · Cited by 188
Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity
Bingham, A., Mamyrova, G., Rother, K. I., Oral, E. A., Cochran, E. K., Premkumar, A., Kleiner, D. E., James‐Newton, L., Targoff, I. N., Pandey, J. P., et al. (2008) · Medicine · doi:10.1097/md.0b013e31816bc604 · Cited by 173
Leptin and the Control of Metabolism: Role for Stearoyl-CoA Desaturase-1 (SCD-1)
Cohen, P., & Friedman, J. M. (2004) · Journal of Nutrition · doi:10.1093/jn/134.9.2455s · Cited by 165
The effect of underweight on female and male reproduction
Boutari, C., Pappas, P. D., Mintziori, G., Nigdelis, M. P., Athanasiadis, L., Goulis, D. G., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154229 · Cited by 181
Giralt, M., Domingo, P., Guallar, J. P., de la Concepción, M. L. R., Alegre, M., Domingo, J. C., & Villarroya, F. (2006) · Antiviral Therapy · doi:10.1177/135965350601100610 · Cited by 155
Colombo, C., Cutson, J. J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2727 · Cited by 147
Self-citationVillanueva, C. J., Vergnes, L., Wang, J., Drew, B. G., Hong, C., Tu, Y., Hu, Y., Xu, P., Xu, F., Sáez, E., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.016 · Cited by 152
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 145
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Chan, J. L., Lutz, K., Cochran, E. K., Huang, W., Peters, Y., Weyer, C., & Görden, P. (2011) · Endocrine Practice · doi:10.4158/ep11229.or · Cited by 147
Mechanisms Regulating Adipocyte Expression of Resistin
Hartman, H. B., Hu, X., Tyler, K. X., Dalal, C. K., & Lazar, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201451200 · Cited by 145
Olswang, Y., Cohen, H., Papo, O., Cassuto, H., Croniger, C. M., Hakimi, P., Tilghman, S. M., Hanson, R. W., & Reshef, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022616299 · Cited by 137
Molecular mechanisms of central leptin resistance in obesity
Jung, C. H., & Kim, M.-S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0020-y · Cited by 140
Lipoatrophic diabetes in Irs1−/−/Irs3−/− double knockout micePreprint
Laustsen, P. G., Michael, M. D., Crute, B. E., Cohen, S. E., Ueki, K., Kulkarni, R. N., Keller, S. R., Lienhard, G. E., & Kahn, C. R. (2002) · Genes & Development · doi:10.1101/gad.1034802 · Cited by 137
Koh, Y.-K., Lee, M.-Y., Kim, J. W., Kim, M., Moon, J., Lee, Y.-J., Ahn, Y., & Kim, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804007200 · Cited by 130
Mulligan, K., Khatami, H., Schwarz, J.-M., Sakkas, G. K., DePaoli, A. M., Tai, V. W., Wen, M. J., Lee, G. A., Grunfeld, C., & Schambelan, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1588 · Cited by 127
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Harrison, S. A., & Neuschwander‐Tetri, B. A. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.06.008 · Cited by 115
Obesity therapy: altering the energy intake-and-expenditure balance sheet
Crowley, V., Yeo, G. S. H., & O’Rahilly, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd770 · Cited by 116
Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia
Tsoli, M., Swarbrick, M. M., & Robertson, G. R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.039 · Cited by 113
Mynarcik, D. C., Combs, T. P., McNurlan, M. A., Scherer, P. E., Komaroff, E., & Gelato, M. C. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212150-00009 · Cited by 113
p300 Coactivates the Adipogenic Transcription Factor CCAAT/Enhancer-binding Protein α
Erickson, R. L., Hemati, N., Ross, S. E., & MacDougald, O. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100128200 · Cited by 108
Leptin: obesity, diabetes and other peripheral effects - a review
Moran, O., & Phillip, M. (2003) · Pediatric Diabetes · doi:10.1034/j.1399-5448.2003.00017.x · Cited by 110
Park, J. Y., Javor, E. D., Cochran, E. K., DePaoli, A. M., & Görden, P. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.010 · Cited by 103
Ectopic fat accumulation: an important cause of insulin resistance in humans.
Yki‐Järvinen, H. (2002) · Europe PMC (PubMed Central) · Cited by 101
Nuclear Envelope, Nuclear Lamina, and Inherited Disease
Worman, H. J., & Courvalin, J. (2005) · International review of cytology · doi:10.1016/s0074-7696(05)46006-4 · Cited by 102
Clinical Classification and Treatment of Congenital and Acquired Lipodystrophy
Chan, J. L., & Oral, E. A. (2010) · Endocrine Practice · doi:10.4158/ep09154.ra · Cited by 93
Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., Mäkimattila, S., Häkkinen, A., Westerbacka, J., Sutinen, J., Vehkavaara, S., & Yki‐Järvinen, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00381.2004 · Cited by 90
Gao, Y.-J., Holloway, A. C., Su, L.-Y., Takemori, K., Lü, C., & Lee, R. M. K. W. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.044 · Cited by 84
Prevalence of Mutations in AGPAT2 Among Human Lipodystrophies
Magré, J., Délepine, M., Maldergem, L. V., Robert, J., Maassen, J. A., Meier, M., Panz, V. R., Kim, C. A., Tubiana‐Rufi, N., Czernichow, P., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1573 · Cited by 84
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 86
PPARγ and metabolism: insights from the study of human genetic variants
Gurnell, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01767.x · Cited by 80
Diseases of adipose tissue: genetic and acquired lipodystrophies
Capeau, J., Magré, J., Lascols, O., Caron, M., Béréziat, V., Vigouroux, C., & Bastard, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331073 · Cited by 78
Lipodystrophy in HIV 1-infected patients: lessons for obesity research
Villarroya, F., Domingo, P., & Giralt, M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803698 · Cited by 76
Disruption of Hepatic Leptin Signaling Protects Mice From Age- and Diet-Related Glucose Intolerance
Huynh, F. K., Levi, J., Denroche, H. C., Gray, S. L., Voshol, P. J., Neumann, U. H., Speck, M., Chua, S. C., Covey, S. D., & Kieffer, T. J. (2010) · Diabetes · doi:10.2337/db10-0074 · Cited by 79
Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function
Takemori, K., Gao, Y., Ding, L., Lü, C., Su, L.-Y., An, W.-S., Vinson, C., & Lee, R. M. K. W. (2007) · Hypertension · doi:10.1161/01.hyp.0000255576.16089.b9 · Cited by 73
Anderlová, K., Křemen, J., Doležalová, R., Housova, J., Haluzíková, D., Kunešová, M., & Haluzı́k, M. (2006) · Physiological Research · doi:10.33549/physiolres.930779 · Cited by 69
Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
Harrison, S. A., & Bisceglie, A. M. D. (2003) · Drugs · doi:10.2165/00003495-200363220-00001 · Cited by 69
Non-alcoholic Steatohepatitis in Children
Roberts, E. A. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.008 · Cited by 64
Sildenafil promotes adipogenesis through a PKG pathway
Zhang, X., Ji, J., Yan, G., Wu, J., Sun, X., Shen, J., Jiang, H., & Wang, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.064 · Cited by 63
Leptin in congenital and HIV-associated lipodystrophy
Tsoukas, M. A., Farr, O. M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.017 · Cited by 58
Non-alcoholic fatty liver disease (NAFLD) in children
Eve, A. R. (2005) · Frontiers in bioscience · doi:10.2741/1699 · Cited by 57
Roberts, E. A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0331 · Cited by 56
Chibby Promotes Adipocyte Differentiation through Inhibition of β-Catenin Signaling
Li, F., Singh, A. M., Mofunanya, A., Love, D. K., Terada, N., Moon, R. T., & Takemaru, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01640-06 · Cited by 55
Qiang, G., Kong, H. W., Xu, S., Pham, H. A., Parlee, S. D., Burr, A. A., Gil, V., Pang, J., Hughes, A., Gu, X., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.005 · Cited by 54
Karamouti, M., Κollia, P., Kallitsaris, A., Vamvakopoulos, N., Kollios, G., & Messinis, I. E. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.076 · Cited by 52
Yu, K., Mo, D., Wu, M., Chen, H., Chen, L., Li, M., & Chen, Y. (2014) · FEBS Journal · doi:10.1111/febs.12792 · Cited by 52
Ben-Romano, R., Rudich, A., Tirosh, A., Potashnik, R., Sasaoka, T., Riesenberg, K., Schlaeffer, F., & Bashan, N. (2004) · Diabetologia · doi:10.1007/s00125-004-1408-5 · Cited by 51
Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice
Colombo, C., Haluzı́k, M., Cutson, J. J., Dietz, K. R., Marcus‐Samuels, B., Vinson, C., Gavrilova, O., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207665200 · Cited by 51
Self-citationZhao, M., & Chen, X. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00601.2014 · Cited by 48
The role of leptin in obesity and the potential for leptin replacement therapy
Feng, H., Zheng, L., Feng, Z., Zhao, Y., & Zhang, N. (2012) · Endocrine · doi:10.1007/s12020-012-9865-y · Cited by 47
Freitas, P., Carvalho, D. M., Santos, A. C., Madureira, A. J., Martínez, E., Pereira, J., Sarmento, A., & Medina, J. L. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-347 · Cited by 49
Tsiodras, S., & Mantzoros, C. S. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.141.152 · Cited by 46
Makkonen, J., Westerbacka, J., Kolak, M., Sutinen, J., Cornér, A., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803635 · Cited by 45
Peroxisome Proliferator-Activated Receptor-γ C190S Mutation Causes Partial Lipodystrophy
Lüdtke, A., Büttner, J., Wu, W., Muchir, A., Schroeter, A., Zinn‐Justin, S., Spuler, S., Schmidt, H., & Worman, H. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2624 · Cited by 45
Kavanagh, K., Espeland, M. A., Sutton‐Tyrrell, K., Barinas‐Mitchell, E., Khoudary, S. R. E., & Wildman, R. P. (2013) · Obesity · doi:10.1002/oby.20077 · Cited by 46
Haluzı́k, M., Dietz, K. R., Kim, J. K., Marcus‐Samuels, B., Shulman, G. I., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2113 · Cited by 45
Self-citationLeptin: a novel therapeutic role in lipodystrophy
Savage, D. B., & O’Rahilly, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15326 · Cited by 48
Paniagua, J. A., Escandell-Morales, J. M., Gil-Contreras, D., de la Rosa, F. J. B., Romero-Jimenez, M., Gómez-Urbano, A., Sánchez‐López, Á. M., Bellido, E., Poyato, A., Calatayud, B. M., et al. (2014) · Nutrition · doi:10.1016/j.nut.2013.07.017 · Cited by 41
Nonalcoholic Fatty Liver Disease in Children
Mager, D. R., & Roberts, E. A. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.10.007 · Cited by 39
A New Transgenic Rat Model of Hepatic Steatosis and the Metabolic Syndrome
Qi, N., Wang, J., Zı́dek, V., Landa, V., Mlejnek, P., Kazdová, L., Pravenec, M., & Kurtz, T. W. (2005) · Hypertension · doi:10.1161/01.hyp.0000161995.64192.2b · Cited by 38
Duszka, K., & Wahli, W. (2020) · Nutrients · doi:10.3390/nu12113476 · Cited by 37
Overview of clinical perspectives and mechanisms of obesity
Collins, S. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20140 · Cited by 36
Leptin: a novel therapeutic role in lipodystrophy
Savage, D. B., & O’Rahilly, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215326 · Cited by 36
Akıncı, B., Köseoğlu, F. D., Önay, H., Yavuz, S., Altay, C., Şimşir, İ. Y., Özışık, S., Demir, L., Korkut, M., Yılmaz, N., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.004 · Cited by 34
Metadata
- Authors
- Reitman, M. L., Arioglu, E., Gavrilova, O., & Taylor, S. I.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Reitman, Marc L.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 11
- Issue
- 10
- Pages
- 410-416
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W4238599503
- Cited by
- 193
- References
- 60
- Citations by year
- 2024: 5 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 9 · 2014: 4 · 2013: 7 · 2012: 3
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- lipoatrophy, partial lipodystrophy, insulin resistance, type 2 diabetes, adipose tissue loss, leptin deficiency, thiazolidinediones, leptin therapy, genetic mutations
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Lipoatrophic, Humans, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review